Biotechnology News

November 13, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today reported financial results for its third...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera announces initiation of Phase 1 trial of IMO-8400, a TLR antagonist with a novel mechanism of action to treat lupus

November 13, 2012

EXTON, Pa.--(BUSINESS WIRE)--Nuron Biotech has completed enrollment in a Phase 3 clinical trial evaluating a proprietary human interferon beta-1b (NU100) for the treatment of relapsing remitting multiple sclerosis.

November 13, 2012

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Murad Inc. announced that Fred Gysi has joined the Murad Family as Chief Financial Officer.

November 13, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed receives technology award from Frost & Sullivan for accelerating the drug development process, enhancing clinical management of patients and enabling discovery of new therapies

November 13, 2012

ROCKFORD, Ill.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Winter/Spring semester application deadline for its Thermo Scientific Pierce Scholarship program, which provides educational...

November 13, 2012

SAN JOSE, Calif. & VALENCIA, Calif.--(BUSINESS WIRE)--Colby Pharmaceutical Company and MannKind Corporation (Nasdaq: MNKD) today announced a license agreement granting Colby exclusive worldwide rights to develop and commercialize disease-...

November 13, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions to present at the Credit Suisse 2012 Healthcare Conference on November 15, 2012 beginning at 9:30 am EST

November 13, 2012

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, is pleased to announce its participation at the MEDICA Conference in Dusseldorf, Germany, during November 14th - 17th, 2012. The...

November 13, 2012

STATE COLLEGE, Pa.--(BUSINESS WIRE)--INDIGO Biosciences, Inc. has added all nine retinoid receptor assays to the company’s significant suite of kits and screening services.

November 13, 2012

LIVERMORE, Calif.--(BUSINESS WIRE)--Compact Particle Acceleration Corporation announces that following technical breakthroughs, it has received a letter of intent for delivery of a proton therapy system to Southwest Oncology Centers.

November 13, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics today announced the appointment of Peter Wirth, former Executive Vice President, Legal and Corporate Development, Chief Risk Officer and Corporate Secretary of Genzyme, as Chairman of the...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that due to the continued progress in its manufacturing operations this year, its supply of Thyrogen® (thyrotropin alfa for injection) has...

November 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Epic Sciences completed a Series B financing to develop highly sensitive companion diagnostics to detect circulating tumor cells and monitor and personalize cancer treatments.

November 13, 2012

TORONTO--(BUSINESS WIRE)--Many segments of the European neurosurgical and neurovascular device market face significant challenges from competing treatments, and as a result the overall market will grow only slowly through 2016

November 13, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics’ multiplexing improves efficiency of drug development, clinical trials and immunogenicity testing
SQI Diagnostics to Present at the European Bioanalysis Forum Open Symposium

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies, today announced the addition of Daniel S. Lynch as...

November 13, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced today that its Enzo Clinical Labs has introduced a new diagnostic test that assists in risk assessment and early detection of lung cancer. It is being made available to physicians...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem announced third quarter 2012 financial results.

November 13, 2012

RICHMOND, Va. & LONDON & SYDNEY--(BUSINESS WIRE)--AmpliPhi and Special Phage Services are formally combined. Ampliphi combines expertise in bacteriophage therapies to create a pipeline of anti-bacterials to address antibiotic resistant...

November 13, 2012

JERUSALEM--(BUSINESS WIRE)--Tiltan Pharma Ltd. today announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment...

November 13, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Creates Hepatitis B Clinical Advisory Board and Names Dr. Robert Gish Chairman to assist with ARC-520 HBV clinical candidate

November 13, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced positive results from an open-label, randomized, crossover study comparing the systemic availability of MTX Medi-Jet to oral methotrexate (MTX) in adult patients...

November 13, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that two poster presentations featuring updated KALBITOR® (ecallantide) data in pediatric patients with hereditary angioedema (HAE) and HAE patients with abdominal...

November 13, 2012

CHICAGO--(BUSINESS WIRE)--Avery Dennison Corporation (NYSE:AVY) has renamed and repositioned its medical solutions group as Vancive Medical Technologies™.

November 13, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Swedish specialty pharmaceutical company Orexo (STO:ORX) today communicated that its partner Kyowa Hakko Kirin Co., Ltd has submitted a New Drug Application (“NDA”) in Japan for KW-2246 (Abstral...

November 13, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced the publication and filing of a circular to shareholders convening an extraordinary general meeting (“EGM”) to be held in the Davenport Hotel, 8/10 Merrion Street Lower,...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced that management will host a conference call on Tuesday, November 13, 2012 at 8:00 a.m. ET to discuss the restructuring...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that they and Tekmira Pharmaceuticals Corporation have restructured their relationship with a new licensing agreement and have resolved all litigation...

November 12, 2012

WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--PerkinElmer Acquires China-based Infectious Disease Diagnostics Company

November 12, 2012

BOSTON--(BUSINESS WIRE)--Bristol-Myers Squibb’s Investigational Hepatitis C Compounds Lambda and Daclatasvir Plus Ribavirin Achieved SVR12 in 93% of Genotype 1b Treatment-Naive Patients In Phase IIb Study

November 12, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. today announced that Neil K. Warma, President & CEO, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14 in New York City.

November 12, 2012

DALLAS--(BUSINESS WIRE)--Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it expects to file its quarterly report on Form 10-Q on November 14, 2012. This report will detail DDOO’s results of operations and financial position...

November 12, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Paris:ALCLS), the genome-engineering specialist, was honored to welcome Professor Yamanaka, this year’s Nobel laureate in medicine, for a meeting with the Group's teams at its Paris headquarters...

November 12, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--Insight Genetics, Inc. today announced it has received two Small Business Innovation Research (SBIR) contracts from the National Cancer Institute (NCI) to continue its work developing diagnostic tests that...

November 12, 2012

NIJMEGEN, Netherlands--(BUSINESS WIRE)--The researchers in this article propose a neuro-anatomical model of neurofeedback, where neurofeedback results in falling asleep faster and better being able to maintain sleep.

November 12, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ), a vertically integrated biosciences and clinical laboratory company, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be...

November 12, 2012

EAST LANSING, Mich.--(BUSINESS WIRE)--MichBio, the association for Michigan’s biosciences industry, welcomed approximately 300 bioscience professionals and service providers to its eighth annual Expo & Conference held November 7-8 at the...

November 12, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) to Present at the Credit Suisse 2012 Healthcare Conference on November 14, 2012

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Discovery Presents Preclinical Data on Highly Selective IRAK4 Inhibitors for the Treatment of Rheumatic Diseases

November 12, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--PATH’s Drug Development program announced today the completion of two phase 1 clinical studies for iOWH032—its investigational new drug to treat acute secretory diarrhea caused by diseases such as...

November 12, 2012

DENVER--(BUSINESS WIRE)--The AspirinWorks Test from Corgenix Medical Corporation has received approval from the SFDA to begin marketing the aspirin effect test in China.

November 12, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

November 12, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Presents New Clinical Safety Data From the Pediatric Development Program for ZETONNA® at ACAAI Annual Meeting

November 12, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced new clinical trial results showing the subcutaneous (SC) formulation of Orencia® (abatacept) on a background of methotrexate (MTX) was similar to Humira® (...

November 12, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the atrial fibrillation drug market will experience dramatic growth over the next...

November 12, 2012

MILAN--(BUSINESS WIRE)--Sorin Group acquires Neurotech SA, developer of neurostimulation devices. Acquisition will accelerate the time to market Sorin’s neuromodulation therapies to treat Heart Failure.

November 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals announces Third Quarter 2012 Financial REsults and expects near-term milestones in autoimeune disease drug development programs.